HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Machiko Ikegami Selected Research

Pulmonary Surfactant-Associated Protein B

12/2005Reversibility of lung inflammation caused by SP-B deficiency.
3/2003Surfactant protein B inhibits endotoxin-induced lung inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Machiko Ikegami Research Topics

Disease

29Pneumonia (Pneumonitis)
03/2012 - 02/2002
23Inflammation (Inflammations)
03/2012 - 02/2002
18Lung Injury
10/2010 - 02/2002
12Chorioamnionitis
02/2012 - 03/2003
8Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2014 - 10/2004
7Fibrosis (Cirrhosis)
04/2014 - 03/2003
7Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2014 - 09/2007
6Emphysema
01/2020 - 10/2002
6Lung Diseases (Lung Disease)
09/2013 - 10/2002
6Bronchopulmonary Dysplasia
05/2008 - 03/2002
4Respiratory Insufficiency (Respiratory Failure)
01/2013 - 09/2003
4Weight Loss (Weight Reduction)
01/2011 - 06/2008
3Pulmonary Hypertension
10/2009 - 09/2007
3Hyperoxia
08/2009 - 08/2002
3Acute Lung Injury
08/2009 - 09/2002
2Pulmonary Emphysema
01/2020 - 10/2002
2Cachexia
04/2014 - 09/2007
2Adenoma (Adenomas)
01/2013 - 04/2008
2Hypoxia (Hypoxemia)
02/2012 - 08/2006
2Fetal Weight
03/2011 - 11/2003
2Vascular Remodeling
06/2008 - 12/2004
2Premature Birth (Birth, Premature)
05/2008 - 05/2002
2Premature Obstetric Labor (Premature Labor)
04/2004 - 09/2002
2Body Weight (Weight, Body)
01/2003 - 03/2002
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Newborn Respiratory Distress Syndrome
01/2014
1Adenocarcinoma
01/2013
1Neoplasms (Cancer)
01/2013
1Obesity
03/2012
1Leukocytosis (Pleocytosis)
07/2010
1Pulmonary Alveolar Proteinosis
07/2010
1Patent Ductus Arteriosus
05/2008

Drug/Important Bio-Agent (IBA)

30Surface-Active Agents (Surfactants)IBA
01/2014 - 03/2002
21EndotoxinsIBA
06/2008 - 02/2002
17Proteins (Proteins, Gene)FDA Link
04/2014 - 06/2002
12LipidsIBA
03/2012 - 06/2002
8CytokinesIBA
10/2010 - 03/2003
7Betamethasone (Celestone)FDA Link
02/2012 - 01/2003
7Messenger RNA (mRNA)IBA
01/2012 - 03/2003
7Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
07/2010 - 06/2002
6Interleukin-8 (Interleukin 8)IBA
01/2012 - 11/2003
5Interleukin-6 (Interleukin 6)IBA
01/2012 - 08/2002
5Interleukin-1 (Interleukin 1)IBA
10/2010 - 03/2002
5Transforming Growth Factor alpha (TGF-alpha)IBA
02/2010 - 08/2007
4Doxycycline (Periostat)FDA LinkGeneric
04/2014 - 09/2003
4CollagenIBA
02/2010 - 12/2004
4IgA receptor (protein B)IBA
08/2009 - 03/2003
3Transforming Growth Factors (Transforming Growth Factor)IBA
04/2014 - 03/2012
3ErbB Receptors (EGF Receptor)IBA
04/2014 - 06/2008
3GlucocorticoidsIBA
02/2012 - 09/2002
3Oxygen (Dioxygen)IBA
08/2009 - 02/2002
3LipopolysaccharidesIBA
05/2009 - 08/2005
3Phospholipids (Phosphatides)FDA LinkGeneric
06/2008 - 10/2002
3Interleukin-1alpha (Interleukin 1 alpha)IBA
09/2006 - 03/2002
2CCAAT-Enhancer-Binding ProteinsIBA
01/2020 - 01/2013
2Urethane (Ethyl Carbamate)IBA
01/2013 - 04/2008
2Sirolimus (Rapamycin)FDA Link
01/2011 - 11/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2010 - 07/2003
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2009 - 11/2005
2Phosphatidylcholines (Phosphatidylcholine)IBA
04/2008 - 08/2006
2Pulmonary Surfactants (Pulmonary Surfactant)IBA
11/2007 - 10/2004
2Metalloproteases (Metalloproteinases)IBA
08/2006 - 06/2002
2Pulmonary Surfactant-Associated Protein BIBA
12/2005 - 03/2003
2AT 130IBA
05/2005 - 03/2004
2Saline SolutionIBA
11/2003 - 10/2002
2acivicin (AT 125)IBA
01/2003 - 08/2002
1Serine Proteases (Serine Protease)IBA
01/2020
1LigandsIBA
04/2014
1IntegrinsIBA
04/2014
1Hydroxyproline (4 Hydroxyproline)IBA
04/2014
1Sorting NexinsIBA
01/2013
1Phosphotransferases (Kinase)IBA
01/2013
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
10/2012
1CholesterolIBA
03/2012
1Fatty Acids (Saturated Fatty Acids)IBA
03/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2012
1AZD 6244IBA
03/2012
1Protein Isoforms (Isoforms)IBA
02/2012
1LeptinIBA
03/2011
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2011
1AutoantibodiesIBA
07/2010
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2010
1PPAR gammaIBA
07/2010
1PX-866IBA
02/2010
1TOR Serine-Threonine KinasesIBA
11/2009
1EstersIBA
09/2009
1nicotinanilideIBA
09/2009
1Interleukin-8B ReceptorsIBA
09/2009
1CCAAT-Enhancer-Binding Protein-alphaIBA
08/2009
1Peroxidase (Myeloperoxidase)IBA
05/2009
1Amyloid (Amyloid Fibrils)IBA
05/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2008
1Gefitinib (Iressa)FDA Link
06/2008
1Tyrosine Kinase InhibitorsIBA
06/2008
1Ibuprofen (Motrin)FDA LinkGeneric
05/2008
1Epithelial Sodium ChannelsIBA
05/2008

Therapy/Procedure

3Therapeutics
03/2012 - 11/2007
3Artificial Respiration (Mechanical Ventilation)
03/2004 - 02/2002
2Aftercare (After-Treatment)
04/2003 - 10/2002
1Resuscitation
05/2010